Use of tranexamic acid is not associated with complications following bipolar hemiarthroplasty for metastatic disease.

Aaron OwenElizabeth P WellingsCody C WylesBrandon J YuanPeter S RoseMatthew T Houdek

Published in: Journal of surgical oncology (2020)

Oncology patients are a high-risk population for thromboembolic events. This initial study supports the safe use of TXA intraoperatively in femoral hemiarthroplasty performed for metastatic disease.

Keyphrases

end stage renal disease
squamous cell carcinoma
small cell lung cancer
ejection fraction
newly diagnosed
chronic kidney disease
hip fracture
palliative care
peritoneal dialysis
bipolar disorder
risk factors
total hip arthroplasty
atrial fibrillation
patient reported outcomes